CMS Blocks 11 Medical Equipment Suppliers Tied to $3.4 Billion in Suspected Fraud

For older adults and people with disabilities who rely on Medicare, durable medical equipment like wheelchairs, catheters and orthotic braces is not a luxury. It is the difference between independence and dependence. So when federal officials say billions of dollars meant to fund that equipment were siphoned off by companies gaming the system, it lands as more than a budget story. It is a story about trust, and about whether the money set aside for vulnerable patients actually gets there.

The Centers for Medicare & Medicaid Services announced Monday that it has identified 11 medical supply companies it will now block from receiving payments under Medicare Advantage or Medicare Part D. CMS says these firms were involved in more than $3.4 billion in fraudulent billing practices across 2025 and 2026. That is not a typo. Billion, with a b.

The pattern CMS describes reads like a checklist of red flags. These companies had filed no claims before last year, then suddenly appeared with a flood of billing. They used improper billing practices. Some submitted claims for medical equipment for patients who were already dead. Others shipped or billed for supplies that beneficiaries never received and never asked for in the first place.

Think of it like a landlord charging rent on an apartment that was never leased, to a tenant who moved out months ago. The bill still gets sent. Someone, somewhere, is supposed to pay it. In this case, that someone was the Medicare Trust Funds, financed by taxpayers and premium-paying beneficiaries alike.

CMS says it is working with the Department of Health and Human Services Office of Inspector General to make sure these 11 companies cannot collect payment under Medicare Advantage or Part D. Four of the suppliers had already been barred from billing traditional Medicare. They responded, according to CMS, by pivoting to Medicare Advantage plans instead, apparently hoping the private-plan pathway would draw less scrutiny.

Two Cases That Illustrate the Scale

CMS singled out two examples it called "egregious," together accounting for nearly $24 million in claims. A Florida-based provider submitted $18.4 million in catheter claims over just two days in December 2025. On Dec. 15, that meant $6.1 million in claims for 500 individuals. The very next day, the same provider filed $12.3 million in claims covering 777 beneficiaries. Two days. Nearly 1,300 people. Over $18 million.

A second case out of Texas involved a supplier that billed $5.5 million for orthotics. When CMS contacted six of the listed beneficiaries directly, all six said the same thing: they had never heard of the company, never ordered the supplies and did not need orthotics in the first place. Investigators also found claims from this same supplier for nine beneficiaries dated after those individuals had died. On top of that, CMS determined the company was not even operating out of the location it claimed.

Every one of the 11 suppliers now on CMS's Preclusion List had submitted claims for beneficiaries later found to be deceased. In both the Texas and Florida cases, CMS says it caught the payments before they went out the door, intercepting the money rather than clawing it back after the fact. That distinction matters. Recovering fraudulent payments after they have already left the Treasury is slow and often incomplete. Stopping them before they clear is far more effective, and far cheaper for taxpayers.

CMS Administrator Mehmet Oz, M.D., framed the action as part of a broader philosophy shift at the agency. "Brazen scams like these have plagued Medicare for decades, but under President Trump's leadership and working with the White House Anti-Fraud Task Force, CMS is protecting the Medicare Trust Funds and its beneficiaries by using advanced data analytics to identify fraud networks and stop suspicious payments before the check clears," Oz said in the announcement.

This latest action does not stand alone. It fits into a pattern of enforcement that has been building for months. Back in February, CMS reported that a six-month moratorium on Medicare enrollment for certain DME suppliers had already prevented an estimated $1.5 billion in fraudulent bills. That moratorium ran its course and ended on Aug. 27, which raises a natural question about what happens to enforcement pressure once a temporary freeze lifts. Monday's announcement suggests the answer, at least for now, is that CMS intends to keep pushing rather than easing off.

The broader umbrella here is something CMS calls the Comprehensive Regulations to Uncover Suspicious Healthcare initiative, shortened to CRUSH. The name is blunt, and so is the goal: find strategies that work across multiple programs at once, rather than treating Medicare, Medicaid, the Children's Health Insurance Program and the Affordable Care Act marketplaces as separate silos with separate fraud problems. Fraud networks do not respect those boundaries, and increasingly, neither does the enforcement strategy meant to catch them.

Why It Matters

Fraud schemes like these are often described in dollar figures, and the numbers here are genuinely staggering. But the real cost shows up somewhere else: in a system that beneficiaries and taxpayers need to trust. Every dollar diverted through fake catheter orders or ghost billing for deceased patients is a dollar that did not go toward actual care, and it is also a dent in the credibility of a program that tens of millions of Americans depend on.

There is a harder question underneath the enforcement wins, too. Using advanced data analytics to catch fraud before payment is a genuine improvement over chasing money after it is gone. But it also means the system was vulnerable enough, for years, to let companies with no billing history suddenly submit claims for hundreds of people in a single day without immediate scrutiny. Closing that gap protects beneficiaries. It also raises the uncomfortable point that the gap existed at all, for as long as it did.